CSIR labs NCL and IGIB sign Licensing agreement with Ahammune Biosciences for Vitiligo drug development

CSIR-National Chemical Laboratory (CSIR-NCL), Pune and CSIR- Institute of Genomics and Integrative Biology (CSIR-IGIB), New Delhi together signed a Patent Licensing agreement with Ahammune Biosciences Pvt. Ltd., Pune for Vitiligo drug development on March 2, 2017. Ahammune is a resident incubatee company of Venture Center.

Ahammune Biosciences is an innovation-led drug discovery start-up company with the vision to find a new drug for the debilitating skin disorder, Vitiligo. It is the most common depigmenting disease with over 80 million people affected by it.